Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston and San Francisco Bay Area. Currently Qiming Venture Partners manages nine US Dollar funds and five RMB funds with $5.3 billion assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growing stages.
Qiming Venture Partners is a top-tier VC firm with outstanding reputation. Qiming has been widely recognized by investors from around the world and has become an ideal VC firm for entrepreneurs. With our exceptional investment performances, Qiming has won multiple world-renowned venture capital awards.
We are committed to finding great companies for the future and bring long-term value to societies. Our investment team spends a lot of time researching industry trends, technology developments, and changes in consumer habits. Through these studies, we hope to capture a huge future market as early as possible. At the same time, we also attach great importance to in-depth and detailed due diligence. We make comprehensive contact with entrepreneurs, through a deep understanding of the business operations and scientific research data, we can better grasp investment opportunities and assess investment risks.
Another essential component of our investment strategy is “focus”. We hope to have good insights and rich contacts for the industries we care about, truly understand the projects we invested in, be able to help after the investment, and form an ecosystem within our portfolio companies, to help start-ups grow from multiple perspectives.
Since our inception in 2006, we have been in touch with tens of thousands of founding teams of startup companies.
On average, one out of 30 companies receives our funding. Seventy percent of our investments are in Series-A, and many of our portfolio companies will become industry leaders in less than seven years.